For instance, Khalifa et al. reported that 33.3% of CMV pp65 antigenemia positive patients in SOT have the HLA-A * 02 genotype, while patients with HLA-A * 01 (57.1%) had a protective effect against CMV infection [46]. This evidence concerns the gene HLA-A and cytomegalovirus infection.